AbstractObjectivesWe sought to investigate the mechanism responsible for the occurrence of anticardiac receptor autoantibodies.BackgroundIncreasing evidence suggests the involvement of autoimmune mechanisms in the pathogenesis of a number of cardiovascular diseases. Among them, the biologic, functional and pathogenic properties of anticardiac receptor antibodies have been extensively investigated. However, the mechanism responsible for the occurrence of anticardiac receptor autoantibodies remains poorly understood.MethodsTwo rat models (aortic banding [AB] and adriamycin [ADR] groups) were constructed. Determination of cardiac function and morphology and T-lymphocyte subtypes, enzyme-linked immunosorbent assay and cardiomyocyte cultures wer...
Dilated cardiomyopathy (DCM) is a common cause of heart failure. After the identification of several...
Cardiac activity of autoantibodies (AABs) directed against β1-adrenoceptor (β1-AR) has been proposed...
Mediastinal lymphadenopathy and auto-antibodies are clinical phenomena during ischemic heart failure...
AbstractObjectivesWe sought to investigate the mechanism responsible for the occurrence of anticardi...
Background—Antibodies to the 1-adrenergic receptor (1AR) are detected in a substantial number of pat...
AbstractOBJECTIVESOur study attempted to gain further understanding of the allosteric effects of hum...
BACKGROUND: Agonistic autoantibodies to the alpha(1)-adrenergic receptor occur in nearly half of pat...
BACKGROUND: Autoantibodies directed against the beta1-adrenergic receptor have been described in pat...
β3-adrenoceptors (β3-ARs) mediate a negative inotropic effect in human ventricular cardiomyocytes, w...
OBJECTIVES: Our study attempted to gain further understanding of the allosteric effects of human aut...
β3-Adrenoceptors (β3-ARs) mediate a negative inotropic effect in human ventricular cardiomyocytes, w...
AbstractOBJECTIVESWe investigated whether autoantibodies against the human beta-adrenergic receptor ...
ß1- and ß3-adrenoceptor (AR) auto-antibodies were detected in patients with dilated cardiomyopathy. ...
Objective To determine whether autoantibodies against PI-adrenergic and M-2-muscarinic receptors are...
BACKGROUND: Agonistic autoantibodies to the alpha(1)-adrenergic receptor occur in nearly half of pat...
Dilated cardiomyopathy (DCM) is a common cause of heart failure. After the identification of several...
Cardiac activity of autoantibodies (AABs) directed against β1-adrenoceptor (β1-AR) has been proposed...
Mediastinal lymphadenopathy and auto-antibodies are clinical phenomena during ischemic heart failure...
AbstractObjectivesWe sought to investigate the mechanism responsible for the occurrence of anticardi...
Background—Antibodies to the 1-adrenergic receptor (1AR) are detected in a substantial number of pat...
AbstractOBJECTIVESOur study attempted to gain further understanding of the allosteric effects of hum...
BACKGROUND: Agonistic autoantibodies to the alpha(1)-adrenergic receptor occur in nearly half of pat...
BACKGROUND: Autoantibodies directed against the beta1-adrenergic receptor have been described in pat...
β3-adrenoceptors (β3-ARs) mediate a negative inotropic effect in human ventricular cardiomyocytes, w...
OBJECTIVES: Our study attempted to gain further understanding of the allosteric effects of human aut...
β3-Adrenoceptors (β3-ARs) mediate a negative inotropic effect in human ventricular cardiomyocytes, w...
AbstractOBJECTIVESWe investigated whether autoantibodies against the human beta-adrenergic receptor ...
ß1- and ß3-adrenoceptor (AR) auto-antibodies were detected in patients with dilated cardiomyopathy. ...
Objective To determine whether autoantibodies against PI-adrenergic and M-2-muscarinic receptors are...
BACKGROUND: Agonistic autoantibodies to the alpha(1)-adrenergic receptor occur in nearly half of pat...
Dilated cardiomyopathy (DCM) is a common cause of heart failure. After the identification of several...
Cardiac activity of autoantibodies (AABs) directed against β1-adrenoceptor (β1-AR) has been proposed...
Mediastinal lymphadenopathy and auto-antibodies are clinical phenomena during ischemic heart failure...